Back to top
more

Nu Skin Enterp: (NUS)

(Delayed Data from NYSE)

 Add to portfolio

$32.84 USD

32.84
1,082,068

-0.10 (-0.30%)

Updated Feb 10, 2016 04:02 PM ET

Volume: 1,082,068

Open: $33.00

Prior Close: $32.94

Is NUS a
Buy, Hold or Sell?

See its Zacks Rank in our free stock analysis report.

Get Free Report for NUS

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Company Summary

Nu Skin is a premier anti-aging company. The company's anti-aging products feature the ageLOC line of products including ageLOC Tru Face Essence Ultra firming serum, the ageLOC TR90 weight management and body shaping system, ageLOC R2 nutritional supplement, and ageLOC Transformation daily skin care system.

General Information

NU SKIN ENTERP

75 WEST CENTER ST

PROVO, UT 84601

Phone: 801-345-1000

Fax: 801-345-5999

Web: http://www.nuskinenterprises.com

Email: spond@nuskin.com

Industry COSMETICS&TLTRS
Sector Consumer Staples
Fiscal Year End December
Last Reported Quarter 12/31/2015
Next EPS Date 2/11/2016

EPS Information

Current Quarter EPS Consensus Estimate 0.72
Current Year EPS Consensus Estimate 2.87
Estimated Long-Term EPS Growth Rate NA
Next EPS Report Date 2/11/2016

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 32.94
52 Week High 62.87
52 Week Low 29.52
Beta 1.37
20 Day Moving Average 983,790.88
Target Price Consensus 39.80

NUS

% Price Change
4 Week -0.60
12 Week 3.29
YTD -11.72
% Price Change Relative to S&P 500
4 Week 4.04
12 Week 14.35
YTD -2.64
Share Information
Shares Outstanding (millions) 57.23
Market Capitalization (millions) 1,885.19
Short Ratio 12.82
Last Split Date NA
Dividend Information
Dividend Yield 4.25%
Annual Dividend $1.40
Payout Ratio 0.47
Change in Payout Ratio NA
Last Dividend Payout / Amount 11/18/2015 / $0.35

Fundamental Ratios

P/E
P/E (F1) 10.35
Trailing 12 Months 11.13
PEG Ratio NA
EPS Growth
vs. Previous Year -25.00%
vs. Previous Quarter 12.00%
   
Sales Growth
vs. Previous Year -10.57%
vs. Previous Quarter 1.98%
   
Price Ratios
Price/Book 2.20
Price/Cash Flow 6.61
Price / Sales 0.83
ROE
12/31/15 NA
9/30/15 19.45
6/30/15 21.11
ROA
12/31/15 NA
9/30/15 11.06
6/30/15 12.23
Current Ratio
12/31/15 NA
9/30/15 1.89
6/30/15 1.92
Quick Ratio
12/31/15 NA
9/30/15 1.26
6/30/15 1.19
Operating Margin
12/31/15 NA
9/30/15 7.73
6/30/15 8.32
Net Margin
12/31/15 NA
9/30/15 6.29
6/30/15 8.32
Pre-Tax Margin
12/31/15 NA
9/30/15 10.01
6/30/15 13.04
Book Value
12/31/15 NA
9/30/15 14.97
6/30/15 15.58
Inventory Turnover
12/31/15 NA
9/30/15 1.56
6/30/15 1.30
Debt-to-Equity
12/31/15 NA
9/30/15 0.22
6/30/15 0.20
Debt to Capital
12/31/15 NA
9/30/15 17.79
6/30/15 16.39